Airway Medix Spółka Akcyjna financials

Airway Medix Spółka Akcyjna

Country: PL Reporting currency: PLN Latest annual report: 2021-12-31
LEI: 259400MDMODKWHZ2EU17
Source filing ↗
Financial statements (PLN, as reported — unscaled; 103 line items across 2 annual periods)
Line item 20212020
Income statement
Revenue PLN 6.0KPLN 257.0K
Other income PLN 20.1MPLN 92.0K
Raw materials & consumables used PLN 0PLN 0
Depreciation & amortisation PLN 0PLN 0
Finance costs PLN 1.5MPLN 767.0K
Profit before tax -PLN 9.4M-PLN 2.0M
Income tax expense -PLN 2.3MPLN 388.0K
Profit for the year -PLN 7.0M-PLN 2.4M
— attributable to owners -PLN 7.0M-PLN 2.4M
— attributable to NCI PLN 0PLN 0
Total comprehensive income -PLN 6.7M-PLN 2.2M
Per share
Basic EPS PLN -0.12PLN -0.04
Diluted EPS PLN -0.12PLN -0.04
Free cash flow / share PLN -0.10PLN -0.04
Cash flow statement
Net cash from operating activities -PLN 5.9M-PLN 2.2M
Net cash from investing activities PLN 0-PLN 5.0M
Purchase of PP&E (capex) PLN 0PLN 7.0K
Net cash from financing activities PLN 3.7MPLN 8.7M
Proceeds from borrowings PLN 3.7MPLN 9.9M
Repayments of borrowings PLN 0PLN 917.0K
Lease liability payments PLN 0PLN 215.0K
Net change in cash -PLN 2.1MPLN 1.5M
Balance sheet
Total assets PLN 44.5MPLN 51.5M
Non-current assets PLN 38.6MPLN 29.0M
Property, plant & equipment PLN 89.0KPLN 2.4M
Current assets PLN 5.9MPLN 22.4M
Inventories PLN 332.0KPLN 220.0K
Trade & other receivables PLN 510.0KPLN 780.0K
Cash & equivalents PLN 29.0KPLN 2.2M
Total equity PLN 23.9MPLN 30.7M
— attributable to owners PLN 23.9MPLN 30.7M
Non-controlling interests PLN 0PLN 0
Non-current liabilities PLN 2.3MPLN 7.9M
Long-term borrowings PLN 131.0KPLN 117.0K
Lease liabilities (non-current) PLN 0PLN 2.6M
Current liabilities PLN 18.3MPLN 13.0M
Lease liabilities (current) PLN 0PLN 121.0K
Trade & other payables PLN 3.8MPLN 2.1M
Deferred tax liabilities PLN 357.0KPLN 3.3M
Derived metrics
Free cash flow -PLN 5.9M-PLN 2.3M
Net margin -117400.0%-923.7%
Return on equity -29.5%-7.7%
Cash conversion ratio 0.83×0.95×
Capex coverage -321.14×
Other reported items
Adjustments For Decrease Increase In Inventories -PLN 112.0K-PLN 29.0K
Adjustments For Decrease Increase In Trade and Other Receivables -PLN 638.0KPLN 336.0K
Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss PLN 14.3MPLN 19.0K
Adjustments For Increase Decrease In Employee Benefit Liabilities PLN 759.0K-PLN 194.0K
Adjustments For Increase Decrease In Trade and Other Payables PLN 1.7M-PLN 194.0K
Adjustments For Unrealised Foreign Exchange Losses Gains PLN 639.0K-PLN 332.0K
Basic Earnings Loss Per Share From Continuing Operations PLN -0.12PLN -0.04
Basic Earnings Loss Per Share From Discontinued Operations PLN 0.00PLN 0.00
Capital Reserve PLN 2.0MPLN 2.0M
Changes In Equity -PLN 6.8M-PLN 2.2M
Comprehensive Income Attributable To Noncontrolling Interests PLN 0PLN 0
Comprehensive Income Attributable To Owners of Parent -PLN 6.7M-PLN 2.2M
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners PLN 5.9MPLN 22.4M
Current Borrowings and Current Portion of Noncurrent Borrowings PLN 13.2MPLN 10.3M
Current Contract Assets PLN 0PLN 14.5M
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale PLN 18.3MPLN 13.0M
Current Provisions For Employee Benefits PLN 1.2MPLN 367.0K
Current Tax Assets Current PLN 0PLN 0
Current Tax Liabilities Current PLN 87.0KPLN 30.0K
Deferred Tax Assets PLN 787.0KPLN 1.4M
Diluted Earnings Loss Per Share From Continuing Operations PLN -0.12PLN -0.04
Diluted Earnings Loss Per Share From Discontinued Operations PLN 0.00PLN 0.00
Effect of Exchange Rate Changes On Cash and Cash Equivalents -PLN 46.0KPLN 46.0K
Equity and Liabilities PLN 44.5MPLN 51.5M
Expense By Nature PLN 1.8MPLN 2.2M
Finance Income PLN 406.0KPLN 995.0K
Impairment Loss On Receivables Or Contract Assets Arising From Contracts With Customers PLN 14.3MPLN 312.0K
Income Taxes Paid Refund Classified As Operating Activities -PLN 45.0KPLN 65.0K
Increase Decrease In Cash and Cash Equivalents -PLN 2.2MPLN 1.5M
Increase Decrease Through Transfers and Other Changes Equity -PLN 85.0KPLN 14.0K
Intangible Assets Other Than Goodwill PLN 37.7MPLN 25.3M
Issued Capital PLN 19.9MPLN 19.9M
Liabilities PLN 20.6MPLN 20.8M
Liabilities Included In Disposal Groups Classified As Held For Sale PLN 0PLN 0
Miscellaneous Other Operating Expense PLN 12.3MPLN 45.0K
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners PLN 0PLN 0
Noncurrent Government Grants PLN 1.5MPLN 1.5M
Noncurrent Provisions For Employee Benefits PLN 321.0KPLN 349.0K
Other Adjustments For Noncash Items -PLN 431.0KPLN 230.0K
Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow -PLN 27.3MPLN 0
Other Adjustments To Reconcile Profit Loss PLN 110.0K-PLN 33.0K
Other Comprehensive Income PLN 377.0KPLN 183.0K
Other Comprehensive Income Net of Tax Exchange Differences On Translation PLN 377.0KPLN 183.0K
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax PLN 377.0KPLN 183.0K
Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax PLN 0PLN 0
Other Current Financial Assets PLN 5.0MPLN 4.7M
Other Expense By Nature PLN 0PLN 0
Other Shortterm Provisions PLN 67.0KPLN 54.0K
Payments For Development Project Expenditure PLN 0PLN 5.0M
Profit Loss From Continuing Operations -PLN 7.0M-PLN 2.4M
Profit Loss From Discontinued Operations PLN 0PLN 0
Reserve of Exchange Differences On Translation PLN 869.0KPLN 492.0K
Reserve of Sharebased Payments PLN 1.1MPLN 1.1M
Retained Earnings -PLN 1.1MPLN 6.0M
Services Expense PLN 1.4MPLN 1.9M
Share Premium PLN 1.2MPLN 1.2M
Social Security Contributions PLN 5.0KPLN 4.0K
Tax Expense Other Than Income Tax Expense PLN 13.0KPLN 70.0K
Wages and Salaries PLN 310.0KPLN 225.0K
Methodology

Every line item above is a fact tagged in Airway Medix Spółka Akcyjna's annual report filed in the European Single Electronic Format (ESEF) under the IFRS taxonomy (ifrs-full) — the income statement, balance sheet and cash-flow statement as the filer reported them. Values are shown as-is, in the reporting currency (PLN), without rescaling; the row labels map to the underlying concept name (e.g. Revenue → ifrs-full:Revenue, Operating profit → ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS → ifrs-full:DilutedEarningsLossPerShare), and any concept without a curated label is shown under “Other reported items” with its de-camel-cased tag name. Only consolidated, default-member facts are shown (segment / dimensional breakdowns are excluded).

“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.

Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.